s.hovland
Submits third-party assay reports on material purchased directly. Based in Osaka.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
5
n=5
Annotations
0
n=0
Median purity submitted
98.93%
n=5
Suppliers covered
4
n=5
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043192 | L-Carnosine | GL Biochem | GLBI-2512-S8068 | Janoshik | 2026-Q2 | 99.28 | 8.71 | 106.8 | Buyer-sourced | 0 | PASS |
| AX-2026-042805 | Retatrutide | GGPeps | GGPE-2512-D2133 | Janoshik | 2026-Q2 | 98.49 | 3.41 | 92.6 | Buyer-sourced | 0 | PASS |
| AX-2025-018919 | CJC-1295 with DAC | TFS | TFS-{CAT}-9795 | Janoshik | 2025-Q1 | 98.93 | 4.07 | 90.8 | Laboratory-retained | 2 | MARGINAL |
| AX-2025-018669 | Tirzepatide | QSC | QSC-2410-R5814 | VendorInvestigate | 2025-Q1 | 98.94 | 5.24 | — | Buyer-sourced | 0 | PASS |
| AX-2024-004934 | Semaglutide | GGPeps | GGPE-2408-Y2528 | Janoshik | 2024-Q3 | 98.09 | 5.60 | — | Buyer-sourced | 0 | PASS |
| Supplier | Records | Median purity |
|---|---|---|
| GGPeps | 2 | n<3 |
| GL Biochem | 1 | n<3 |
| TFS | 1 | n<3 |
| QSC | 1 | n<3 |